What types of strategic partnerships do you support?

We support a wide range of strategic partnerships including in-licensing and out-licensing of products, co-development agreements, contract R&D collaborations, and manufacturing partnerships with CMOs. Each engagement is tailored to the partner’s portfolio, markets, and strategic objectives.

How do you structure licensing and co-development deals?

Licensing and co-development deals are structured based on asset maturity, development responsibilities, regulatory pathways, and commercial potential. We define clear roles, milestones, risk-sharing mechanisms, and value-sharing models that align incentives for all parties across development and commercialization.

Which therapeutic areas and dosage forms do you focus on?

Our network covers a broad range of therapeutic areas including cardiovascular, CNS, oncology, infectious diseases, metabolic, respiratory, gastrointestinal, and dermatology. We work across solid oral, liquids, topicals, injectables, and specialty dosage forms, including complex and value-added generics.

How do you support portfolio planning and optimization?

We perform portfolio reviews that evaluate market dynamics, competition, regulatory complexity, and investment needs. Based on this analysis, we prioritize projects, identify gaps and high-value opportunities, and propose licensing, co-development, or partnership options to balance risk and return.

Can you help with both early-stage and late-stage assets?

Yes. We work with partners across the full lifecycle—from early development and technology assessment to late-stage registration, launch, and lifecycle management. Our role is to connect the right partners and deal structures to move assets efficiently toward the market while protecting long-term value.

Strategic Partnership, Licensing & Portfolio Management

Comprehensive strategic partnership and licensing services to optimize your pharmaceutical portfolio, maximize value creation, and accelerate market access. We facilitate out-licensing, in-licensing, and strategic collaborations across the healthcare value chain.

What We Offer

Strategic partnerships and licensing agreements are essential for pharmaceutical companies seeking to optimize portfolios, access new markets, or leverage complementary capabilities. Our services facilitate successful partnerships through comprehensive deal structuring, negotiation support, and portfolio management.

We work with both licensors and licensees to create value-driven agreements that align incentives, manage risk, and accelerate time-to-market for pharmaceutical products.

Key Benefits

Portfolio Optimization

Strategic evaluation and optimization of product portfolios to maximize value, focus resources, and align with business objectives.

Value Creation

Structured agreements that create value for all parties through aligned incentives, risk-sharing, and revenue optimization.

Market Access

Accelerated market access through strategic partnerships that leverage complementary capabilities and regional expertise.

Risk Mitigation

Comprehensive due diligence and risk assessment to identify and mitigate potential challenges in partnership agreements.

Deal Structuring

Expert negotiation and deal structuring to ensure agreements are fair, comprehensive, and aligned with strategic objectives.

Relationship Management

Ongoing partnership management and support to ensure successful execution and long-term relationship success.

Out-Licensing Process

A systematic approach to out-licensing that maximizes value and ensures successful partnerships.

Key Components in Out-Licensing Agreements

Portfolio Assessment
Comprehensive evaluation of your product portfolio to identify out-licensing opportunities. We assess product value, market potential, competitive landscape, and strategic fit to determine optimal licensing candidates.
Market Analysis & Partner Identification
Market analysis to identify potential licensees with complementary capabilities, market access, and strategic alignment. We develop target partner profiles and conduct outreach to qualified candidates.
Due Diligence & Documentation
Preparation of comprehensive due diligence packages including product data, regulatory status, intellectual property information, and commercial potential. We ensure all documentation is accurate, complete, and compelling.
Deal Structuring & Negotiation
Development of deal structures that align incentives and maximize value. We negotiate key terms including upfront payments, milestones, royalties, territory rights, and performance obligations.
Agreement Execution
Finalization of licensing agreements with comprehensive terms covering intellectual property, regulatory responsibilities, commercialization obligations, and relationship management. We ensure agreements are legally sound and strategically aligned.
Partnership Management
Ongoing support and relationship management to ensure successful execution of licensing agreements, milestone achievement, and long-term partnership success.

Key Components in Licensing Agreements

Financial Terms

Upfront payments and signing fees
Development and regulatory milestones
Sales-based royalties and profit sharing
Minimum sales obligations
Payment terms and currency considerations

Intellectual Property

Patent rights and exclusivity periods
Trademark and branding rights
Know-how and trade secret protection
Improvement rights and ownership
Infringement and enforcement provisions

Territorial Rights

Geographic territory definitions
Exclusive vs. non-exclusive rights
Sub-licensing rights and restrictions
Territory expansion options
Competing product restrictions

Regulatory & Commercial

Regulatory filing and maintenance responsibilities
Commercialization obligations and timelines
Quality and compliance requirements
Supply chain and manufacturing rights
Reporting and audit provisions

Use Cases & Engagement Models

Out-Licensing

Licensing your products or technologies to partners for development, commercialization, or market expansion in specific territories or therapeutic areas.

In-Licensing

Acquiring rights to develop and commercialize products or technologies from other companies to expand your portfolio and market reach.

Co-Development

Collaborative development partnerships that share costs, risks, and rewards while leveraging complementary capabilities and expertise.

Co-Commercialization

Partnerships for joint commercialization of products, sharing marketing, sales, and distribution responsibilities to maximize market penetration.

Portfolio Divestment

Strategic divestment of non-core assets or products to focus resources and optimize portfolio alignment with business objectives.

Strategic Alliances

Long-term strategic alliances that combine capabilities, resources, and market access to create competitive advantages and accelerate growth.

Frequently Asked Questions

What is the typical timeline for completing a licensing agreement?

Timelines vary based on deal complexity, due diligence requirements, and negotiation dynamics. A typical out-licensing process ranges from 6-12 months from initial assessment to agreement execution. In-licensing may take 4-8 months depending on due diligence scope. We provide detailed timelines during the initial assessment phase.
What factors determine licensing deal value?

Deal value is influenced by multiple factors including product stage, market potential, competitive landscape, intellectual property strength, regulatory status, and strategic fit. We conduct comprehensive valuation analyses considering upfront payments, milestone structures, royalty rates, and long-term revenue potential to determine fair market value.
How do you ensure successful partnership execution?

We establish clear governance structures, communication protocols, and performance metrics at the outset. Regular monitoring, milestone tracking, and relationship management ensure alignment and early identification of potential issues. We also provide ongoing support to facilitate successful partnership execution and conflict resolution.
What due diligence is required for licensing agreements?

Due diligence typically includes product data review, regulatory status assessment, intellectual property analysis, financial evaluation, market analysis, and partner capability assessment. We prepare comprehensive due diligence packages and conduct thorough evaluations to identify risks and opportunities, ensuring informed decision-making.
Can you help with portfolio optimization strategies?

Yes, we provide comprehensive portfolio analysis and optimization services. We evaluate product portfolios to identify opportunities for out-licensing, in-licensing, divestment, or strategic partnerships. Our analysis considers strategic fit, resource requirements, market potential, and value creation opportunities to develop actionable portfolio optimization strategies.

Strategic Partnership & Licensing